Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion evidence source_evidence_literature NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion SIO_000772 17558308 NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion wasDerivedFrom befree-2016 NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion wasGeneratedBy ECO_0000203 NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- befree-2016 importedOn "2016-02-19" NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.